Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses

Current Opinion in Rheumatology

Volumn 16, Issue 4, 2004, Pages 374-379

  Suhrbier, Andreas ^a,b   Linn, May La ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Chikungunya virus; Macrophage; Ross River virus; Sindbis virus; Viral arthritis

Indexed keywords

ANALGESIC AGENT; CORTICOSTEROID; INTERLEUKIN 10; NEUTRALIZING ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; VIRUS ANTIBODY; VIRUS VACCINE;

ALPHA VIRUS; ARTHRITIS; CLINICAL FEATURE; DENGUE; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DISEASE EXACERBATION; DOWN REGULATION; DRUG INDUCED DISEASE; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; INFECTIOUS ARTHRITIS; LABORATORY DIAGNOSIS; MACROPHAGE; NONHUMAN; PERSISTENT INFECTION; PHAGOCYTE; PHAGOCYTOSIS; PHAGOSOME; POLYARTHRITIS; PRIORITY JOURNAL; PROTEIN INDUCTION; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; ROSS RIVER ALPHA VIRUS; SERODIAGNOSIS; TREATMENT OUTCOME; VIRUS INFECTION; VIRUS TRANSMISSION;

ALPHAVIRUS INFECTIONS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MACROPHAGES; ROSS RIVER VIRUS; SYNOVIAL MEMBRANE;

EID: 3042624699     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bor.0000130537.76808.26     Document Type: Review

References (51)

1. Harley D, Sleigh A, Ritchie S: Ross River virus transmission, infection, and disease: a cross-disciplinary review. Clin Microbiol Rev 2001, 14:909-932.
2. Fraser JR: Epidemic polyarthritis and Ross River virus disease. Clin Rheum Dis 1986, 12:369-388.
3. Johnson RE PC: Alphaviruses. In Virology. Edited by Fields BN KD, Howley PM, et al. New York: Lippincott-Raven; 1996:843-898.
4. Kiwanuka N, Sanders EJ, Rwaguma EB, et al.: O'nyong-nyong fever in south-central Uganda, 1996-1997: clinical features and validation of a clinical case definition for surveillance purposes. Clin Infect Dis 1999, 29:1243-1250.
5. Tesh RB, Watts DM, Russell KL, et al.: Mayaro virus disease: an emerging mosquito-borne zoonosis in tropical South America. Clin Infect Dis 1999, 28:67-73.
6. Turunen M, Kuusisto P, Uggeldahl PE, et al.: Pogosta disease: clinical observations during an outbreak in the province of North Karelia, Finland. Br J Rheumatol 1998, 37:1177-1180.
7. Brummer-Korvenkontio M, Vapalahti O, Kuusisto P, et al.: Epidemiology of Sindbis virus infections in Finland 1981-96: possible factors explaining a peculiar disease pattern. Epidemiol Infect 2002, 129:335-345.
8. Mylonas AD, Brown AM, Carthew TL, et al.: Natural history of Ross River virus-induced epidemic polyarthritis. Med J Aust 2002, 177:356-360.
9. Harley D, Bossingham D, Purdie DM, et al.: Ross River virus disease in tropical Queensland: evolution of rheumatic manifestations in an inception cohort followed for six months. Med J Aust 2002, 177:352-355.
10. Flexman JP, Smith DW, Mackenzie JS, et al.: A comparison of the diseases caused by Ross River virus and Barmah Forest virus. Med J Aust 1998, 169:159-163.
11. Powers AM, Brault AC, Tesh RB, et al.: Re-emergence of Chikungunya and O'nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J Gen Virol 2000, 81:471-479.
12. Edelman R, Tacket CO, Wasserman SS, et al.: Phase II safety and immunogenicity study of live Chikungunya virus vaccine TSI-GSD-218. Am J Trop Med Hyg 2000, 62:681-685.
13. Heise MT, Simpson DA, Johnston RE: Sindbis-group alphavirus replication in periosteum and endosteum of long bones in adult mice. J Virol 2000, 74:9294-9299.
14. Savolainen E, Kaipiainen-Seppanen O, Kroger L, et al.: Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey. J Rheumatol 2003, 30:2460-2468. In a study of 188 patients with inflammatory joint disease in Finland, 2 had elevated IgM antibodies against Sindbis virus.
15. Ryan PA, Farmer JF, Kay BH, et al.: Itching bites may limit Ross River virus infection. Med J Aust 2003, 178:144.
16. Laine M, Luukkainen R, Jalava J, et al.: Prolonged arthritis associated with Sindbis-related (Pogosta) virus infection. Rheumatology (Oxford) 2000, 39:1272-1274.
17. Aaskov J, Williams L, Yu S: A candidate Ross River virus vaccine: preclinical evaluation. Vaccine 1997, 15:1396-1404.
18. Gangopadhyay A, Jolly PE: Lack of enhancement of caprine arthritis encephalitis virus infection in monocyte-derived macrophage cultures by sera from goats that developed severe arthritis after vaccination and virus challenge. Cell Mol Biol (Noisy-le-grand) 2003, 49:1177-1182. Postvaccine enhancement of viral arthritis may be due to immune complexes.
19. Wallace MJ, Smith DW, Broom AK, et al.: Antibody-dependent enhancement of Murray Valley encephalitis virus virulence in mice. J Gen Virol 2003, 84:1723-1728. Illustration that waning vaccine-induced antibody levels could enhance flavivirus infection.
20. Soden M, Vasudevan H, Roberts B, et al.: Detection of viral ribonucleic acid and histologic analysis of inflamed synovium in Ross River virus infection. Arthritis Rheum 2000, 43:365-369.
21. Linn ML, Aaskov JG, Suhrbier A: Antibody-dependent enhancement and persistence in macrophages of an arbovirus associated with arthritis. J Gen Virol 1996, 77:407-411.
22. Way SJ, Lidbury BA, Banyer JL: Persistent Ross Rivervirus infection of murine macrophages: an in vitro model for the study of viral relapse and immune modulation during long-term infection. Virology 2002, 301:281-292.
23. Clarris BJ, Doherty RL, Fraser JR, et al.: Epidemic polyarthritis: a cytological, virological and immunochemical study. Aust N Z J Med 1975, 5:450-457.
24. Gerszten RE, Garcia-Zepeda EA, Lim YC, et al.: MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999, 398:718-723.
25. Mateo L, Linn ML, McColl SR, et al.: An arthrogenic alphavirus induces monocyte chemoattractant protein-1 and interleukin-8. Intervirology 2000, 43:55-60.
26. Ryman KD, Klimstra WB, Nguyen KB, et al.: Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J Virol 2000, 74:3366-3378.
27. Mahalingam S, Lidbury BA: Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus. Proc Natl Acad Sci USA 2002, 99:13819-13824.
28. Linn ML, Bellett AJ, Parsons PG, et al.: Complete removal of mycoplasma from viral preparations using solvent extraction. J Virol Methods 1995, 52:51-54.
29. Lidbury BA, Simeonovic C, Maxwell GE, et al.: Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice. J Infect Dis 2000, 181:27-34.
30. Linn ML, Mateo L, Gardner J, et al.: Alphavirus-specific cytotoxic T lymphocytes recognize a cross-reactive epitope from the capsid protein and can eliminate virus from persistently infected macrophages. J Virol 1998, 72:5146-5153.
31. Linder S, Heimerl C, Fingerle V, et al.: Coiling phagocytosis of Borrelia burgdorferi by primary human macrophages is controlled by CDC42Hs and Rac1 and involves recruitment of Wiskott-Aldrich syndrome protein and Arp2/3 complex. Infect Immun 2001, 69:1739-1746.
32. Kuipers JG, Zeidler H, Kohler L: How does Chlamydia cause arthritis? Rheum Dis Clin North Am 2003, 29:613-629. Monocyte infection by Chlamydia species and how it may persist despite active immune responses.
33. Mody GM, Parke FA, Reveille JD: Articular manifestations of human immunodeficiency virus infection. Best Pract Res Clin Rheumatol 2003, 17:265-287. Review of HIV arthritis supporting the view that arthritis is due to HIV infection in the joint.
34. Sawada K, Ohnishi K, Fukunaga K, et al.: Granulocyte and monocyte adsorptive apheresis for patients with chronic hepatitis C virus infection: a report on six cases with high plasma viremia. Ther Apher 2003, 7:547-553.
35. Sarmiento RE, Tirado R, Gomez B: Reinfection-induced increase of rubella persistently infected cells in a macrophage-like cell line. Virus Res 1997, 50:15-22.
36. Fu Y, Ishii KK, Munakata Y, et al.: Regulation of tumor necrosis factor alpha promoter by human parvovirus B19 NS1 through activation of AP-1 and AP-2. J Virol 2002, 76:5395-5403.
37. Benoist C, Mathis D: Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat Immunol 2001, 2:797-801.
38. Pendergraft WF 3rd, Preston GA, Shah RR, et al.: Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 2004, 10:72-79. RR virus is listed as a potential inducer of autoantibodies that cause inflammatory vascular disease.
39. Suhrbier A, Linn ML: Suppression of antiviral responses by antibody-dependent enhancement of macrophage infection. Trends Immunol 2003, 24:165-168. Speculative review suggesting that Fc receptor ligation may suppress antiviral activity via interleukin-10 secretion.
40. Li ML, Stollar V: Alphaviruses and apoptosis. Int Rev Immunol 2004, 23:7-24. The cellular pathways involved in alphavirus-induced apoptosis are complex.
41. Linn ML, Gardner J, Warrilow D, et al.: Arbovirus of marine mammals: a new alphavirus isolated from the elephant seal louse, Lepidophthirus macrorhini. J Virol 2001, 75:4103-4109.
42. Hales S, de Wet N, Maindonald J, et al.: Potential effect of population and climate changes on global distribution of dengue fever: an empirical model. Lancet 2002, 360:830-834.
43. Sanders EJ, Rwaguma EB, Kawamata J, et al.: O'nyong-nyong fever in south-central Uganda, 1996-1997: description of the epidemic and results of a household-based seroprevalence survey. J Infect Dis 1999, 180:1436-1443.
44. Lam SK, Chua KB, Hooi PS, et al.: Chikungunya infection: an emerging disease in Malaysia. Southeast Asian J Trop Med Public Health 2001, 32:447-451.
45. Visser LG, Groen J: Arthralgia and rash from Australia caused by Ross river virus. Ned Tijdschr Geneeskd 2003, 147:254-257. Description of a tourist returning to Holland from Australia with RRVD.
46. Eisenhut M, Schwarz TF, Hegenscheid B: Seroprevalence of dengue, chikungunya and Sindbis virus infections in German aid workers. Infection 1999, 27:82-85.
47. Pile JC, Henchal EA, Christopher GW, et al.: Chikungunya in a North American traveller. J Travel Med 1999, 6:137-139.
48. World Health Organization (ed): Public Health Response to Biological and Chemical Weapons: WHO guidance. edn 2. WHO, 2001.
49. Sidwell RW, Smee DF: Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control. Antiviral Res 2003, 57:101-111. Encephalitic alphaviruses as potential bioweapons.
50. Elvin SJ, Bennett AM, Phillpotts RJ: Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus. J Med Virol 2002, 67:384-393.
51. Lundstrom K: Alphavirus vectors for vaccine production and gene therapy. Expert Rev Vaccines 2003, 2:447-459. Review of alphavirus-based vector systems and their potential vaccine and therapeutic applications.